Back in those dismal days of 2020 we were all holed up in our homes and restricted in our ability to do as much as wander around the neighbourhood. Amongst the fearful silence came a wave of conversations. Suddenly it seemed like everyone, and their dog, was piling into Clubhouse.
More ink has been spent on the topic of AI disruption and integration in media than any other topic. Much of the discourse has been around the threat AI-generated content poses to human copy writers and creative professionals. Many threats are overblown but that is a topic for a different time.
What is the business of Google? The normal response is to say, ‘a search engine.’ It’s a convenient answer and it looks to be the case but it’s not correct. Instead, the business of Google is promotion.
In advertising there are those who design assets and those who plan the deployment thereof. The first group of folks work for creative agency. The second work for strategic – also known as planning – agencies. When it comes to medical marketing the strategic agencies are in trouble.
We’re not going to name names. Okay, we’re going to name one but it’s ancillary to the discussion – Twitter.
Audio is BIG. How big? In 2022, Americans allocated over 30% of their media consumption time to the format. However, brands only allocated 6% of ad spend to the format.
Data is everywhere. A few years ago, our meetings were about content and execution. Now, we find ourselves in more and more metric meetings and KPI crash sessions. The flood of information is fun, exciting, and an immense help in building world class campaigns. However, it is easy to lose sight of data fundamentals as our dashboards become prettier and the insights more granular.
The marketing jargon du jour is “Walled Gardens.” Given that Facebook, Google, and Amazon are commonly labelled as Walled Gardens and account for 55% of digital ad spend it would be foolish to ignore the concept. But what exactly is a Walled Garden? And should a pharma marketer value one?
Back in those dismal days of 2020 we were all holed up in our homes and restricted in our ability to do as much as wander around the neighbourhood. Amongst the fearful silence came a wave of conversations. Suddenly it seemed like everyone, and their dog, was piling into Clubhouse.
Read MoreMore ink has been spent on the topic of AI disruption and integration in media than any other topic. Much of the discourse has been around the threat AI-generated content poses to human copy writers and creative professionals. Many threats are overblown but that is a topic for a different time.
Read MoreWhat is the business of Google? The normal response is to say, ‘a search engine.’ It’s a convenient answer and it looks to be the case but it’s not correct. Instead, the business of Google is promotion.
Read MoreIn advertising there are those who design assets and those who plan the deployment thereof. The first group of folks work for creative agency. The second work for strategic – also known as planning – agencies. When it comes to medical marketing the strategic agencies are in trouble.
Read MoreWe’re not going to name names. Okay, we’re going to name one but it’s ancillary to the discussion – Twitter.
Read MoreAudio is BIG. How big? In 2022, Americans allocated over 30% of their media consumption time to the format. However, brands only allocated 6% of ad spend to the format.
Read MoreData is everywhere. A few years ago, our meetings were about content and execution. Now, we find ourselves in more and more metric meetings and KPI crash sessions. The flood of information is fun, exciting, and an immense help in building world class campaigns. However, it is easy to lose sight of data fundamentals as our dashboards become prettier and the insights more granular.
Read MoreThe marketing jargon du jour is “Walled Gardens.” Given that Facebook, Google, and Amazon are commonly labelled as Walled Gardens and account for 55% of digital ad spend it would be foolish to ignore the concept. But what exactly is a Walled Garden? And should a pharma marketer value one?
Read More
